This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We commend the SPRINT (Systolic Blood Pressure Intervention Trial) team1 for including a mechanistic evaluation in the SPRINT trial, reported by Soliman et al.2 In addition to demonstrating clinical effectiveness, understanding how interventions work allows us to determine which are the primary disease processes and which are downstream effects. Such mechanistic understanding focuses the development of new therapies, identifies which are the genuine independent prognostic …
American Heart Association Professional?
Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
This Issue
Article Tools
Share this Article
- Letter by Lewis et al Regarding Article, “Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)”
